Bausch Health
| Company type | Public |
|---|---|
| |
| ISIN | CA0717341071 |
| Industry | Pharmaceuticals |
| Founded | 1959 (as ICN Pharmaceuticals) |
| Founder | Milan Panić |
| Headquarters | Laval, Quebec, Canada |
Key people | Thomas J. Appio (CEO) John Paulson (chairman) Jean-Jacques Charhon (Executive VP & CFO) John S. Barresi (Senior VP & Controller) |
| Revenue | US$9.63 billion (2024) |
| US$1.39 billion (2024) | |
Number of employees | c. 7,000 (2025) |
| Subsidiaries | |
| Website | bauschhealth |
| Footnotes / references | |
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.